To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma.
Clinical trial NCT04443049 · UNKNOWN
Trial details
- NCT number
- NCT04443049
- Sponsor
- Institute of Liver and Biliary Sciences, India
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-10
- Primary completion
- 2022-06-19
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.